You are here:  » About us 

I²DEAL - Combine Forces

I²DEAL stands for International Institute for Dermatological Allergology.

In 2012, the I²DEAL partnership between the Allergie-Centrum-Charité (ACC) and the global pharmaceutical company LEO Pharma A/S from Denmark was established. Opens external link in new windowLEO Pharma as well as the Opens external link in new windowACC are specialized in the research and treatment of skin diseases including the medication development in own labs. The focus is on profound research and treatment of unbearable itch that often comes with skin diseases. Itch is difficult to treat. There is still no reliable medication that grants complete relief. The research in this area is in its infancy.

I²DEAL is committed to promoting the research of allergic skin diseases in order to ease the suffering of many patients affected.  
Within the scope of I²DEAL, basic scientific projects and clinical trials are carried out.

For more details please read our pages. If you have questions or suggestions, please do not hesitate to Opens internal link in current windowcontact us.

The I²DEAL-Team

Please click to enlarge

News

First publication of I²DEAL research projects

"IL-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge", Hawro et al (Allergy 2014)

Read more

I²DEAL Conclusion of Contract on 31 October 2012

On 31 October 2012 the International Institute for Dermatological Allergology was founded in Berlin.

Read more

IDEAL Summer school started

With the start of the IDEAL Summer School, a new training initiative was launched in Berlin with 100 physicians specialized in dermatology, pediatrics...

 Read more